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Abstract  
A key aim of toxicology is the prevention of adverse effects due to toxic hazards. Therefore, the 
dissemination of toxicology research findings must confront two important challenges: one being 
the lack of information on the vast majority of potentially toxic industrial chemicals, and the 
other being the strict criteria for scientific proof usually required for decision-making in regard to 
prevention. The present study ascertains the coverage of environmental chemicals in four 
volumes of Human & Experimental Toxicology and the presentation and interpretation of 
research findings in published articles. Links in SciFinder showed that the 530 articles published 
in four selected volumes between 1984 and 2014 primarily dealt with metals (126 links) and 
other toxicants that have received substantial attention in the past. Thirteen compounds identified 
by U.S. authorities in 2006 as high-priority substances, for which toxicology documentation is 
badly needed, were not covered in the journal issues at all. When reviewing published articles, 
reliance on p values was standard, and non-significant findings were often called “negative”. 
This tradition may contribute to the perceived need to extend existing research on toxic hazards 
that have already been well characterised. Several sources of bias towards the null hypothesis 
can affect toxicology research, but are generally not considered, thus adding to the current 
inclination to avoid false positive findings. In this regard, toxicology is particularly prone to bias 
because of the known paucity of false positives and, in particular, the existence of a vast number 
of toxic hazards which by default are considered innocuous due to lack of documentation. The 
Precautionary Principle could inspire decision-making on the basis incomplete documentation 
and should stimulate a change in toxicology traditions and in toxicology research publication.  
Keywords 
Precaution, public health, research, scientific inference, toxicology 
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Introduction  
Toxicology is the study of the adverse effects of chemical, physical or biological agents on living 
organisms and the ecosystem, including the prevention and amelioration of such adverse effects.1 
An important journal in the field, Human & Experimental Toxicology focuses on experimental 
and clinical studies of functional, biochemical and structural disorders and their causes, antidotes 
and other therapies. Toxicology research is in particular demand, as a substantial part of the total 
burden of disease in industrialized countries has been attributed to environmental factors, 
including chemicals,2 and because documentation is lacking on the health effects of most 
industrial chemicals.3 That said, one must ask if toxicology research and the dissemination of 
results through toxicology journals provide ample support for decision-making on preventing 
toxic hazards.  
Risk assessment has so far relied on the so-called “untested-chemical assumption”, i.e. 
that the lack of documentation means that regulatory action is not required.3 This tradition has 
resulted in exposure limits for a small proportion of substances, and some limits were much too 
high to adequately protect against adverse health effects. For example, current limits for 
perfluorinated compounds in drinking water do not protect against their immunotoxic effects and 
may be more than 100-fold too high.4 Thus, when scientific evidence is incomplete, exposure 
standards are more lenient, and prevention appears less important.  
At least two major aspects deserve attention: the focus of the research and the 
interpretation of the results obtained.5 Given the substantial number of untested chemical 
hazards, toxicology research would be expected to contribute documentation on the lesser-known 
hazards that have raised flags as potential toxicants. However, a recent bibliometric study of 
toxicology and public health journals showed that articles published during the first decade of 
 4 
this millennium primarily addressed chemicals that had already been well studied, and that the 
top-10 substances were all metals.6 Articles from Human & Experimental Toxicology up to 2009 
were included in this bibliometric analysis, and the present study therefore aims to update the 
information through 2014.  
While relying on toxicology research for guidance in regard to prevention needs, 
excessive demands for proof have prevented necessary regulation of toxic hazards.3 The delay in 
decision-making may result in a continued, perhaps increasing, exposure to the suspected hazard. 
The Precautionary Principle (PP) has been proposed for situations of potentially serious or 
irreversible threats to health or to the environment, where the need to act to reduce potential 
hazards – before there is strong proof of harm – should take into account likely present and 
future costs and benefits of action and inaction.7 Thus, preliminary, but reliable evidence may be 
sufficient to justify an intervention to avoid a health hazard that could otherwise lead to serious 
repercussions.  
Demands for solid documentation before regulatory action will inspire continued 
elaboration of hazards that may already be well documented, since firm decisions are being 
deferred until current, perhaps minor, uncertainties can be resolved. Whereas, when decisions are 
PP-based, less extensive evidence would be required, as timely prevention of plausible harm 
would allow acceptance of some uncertainties as being inevitable or impossible to remove within 
at reasonable time frame. In the latter case, research attention can then be steered towards more 
poorly documented hazards that may pose new challenges and inspiration to toxicology research. 
Thus, a less extensive requirement regarding scientific evidence can have significant 
implications as to the ways that research is planned, performed, analysed, interpreted, and 
reported.8 The present study analyses articles from Human & Experimental Toxicology to 
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ascertain how the journal and the toxicology research published in this journal fit in with current 
needs for toxicology documentation.  
Methods 
Subject matter 
To assess the coverage of chemical substances in articles published in Human & Experimental 
Toxicology (and its predecessor, Human Toxicology), a bibliometric analysis was carried out 
using an internet-based database, SciFinder, that refers to individual substances by their 
Chemical Abstract Service (CAS) registry numbers.6 Articles published in 2014 through to the 
October issue, as well as previous (complete) volumes published in 1984, 1994, and 2004 were 
scrutinized. The CAS numbers were translated into common names, and the frequencies were 
tabulated.  
A separate search using SciFinder was made to ascertain to what extent thirteen high-
priority environmental chemicals have been covered in Human & Experimental Toxicology. The 
thirteen high-production substances were identified by the U.S. Environmental Protection 
Agency in 2006 as lacking both a robust hazard data set and exposure information.9 Despite the 
need for documentation of these compounds, they were only represented by a total of 352 links 
to scientific articles among the 180,000 articles published in the 72 journals during 2000-2009.6 
Additionally, very few articles on these compounds appeared during subsequent years.5 The 
present study explored the coverage in Human & Experimental Toxicology volumes from 2004 
and 2014; those substances that had been most frequently covered in toxicology journals were 
sought in the present journal in all volumes between 2006 and 2014.  
 
Scientific inference 
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Toxicology research relies on statistical testing to assess whether or not an observed effect could 
be considered a possible result of natural variability. “Statistical significance” is achieved when 
the probability p is less than 5% for results that deviate at least as much as those observed from 
the expectation under the null hypothesis. However, when relying on the 5% limit, many 
potentially causal associations may inadvertently be ruled out, e.g. because the study was too 
small to reach statistical significance.10 In addition, erroneous acceptance of the null hypothesis 
may be due to commonly occurring exposure misclassification, especially in human studies, but 
this bias is frequently ignored.11 Similarly, several other weaknesses present in toxicology 
research can easily bias the findings towards false negative conclusions (Table 1).7, 12 
Nonetheless, the failure to reject the null hypothesis has often been interpreted as an indication of 
safety, although the lack of a statistically significant association alone in no way purports that 
there is an absence of an effect.3 Accordingly, the scientific inference drawn from toxicology 
research needs to judge the p values in light of the study characteristics. 
Prudent interpretation of toxicology research requires that 1) the sources of uncertainty 
and potential underestimation of risk are identified and taken into account; 2) the results are 
presented with statistical confidence limits; 3) the results are interpreted in light of the statistical 
power of the study; and 4) the upper confidence limit is considered as part of a worst-case 
scenario when interpreting the results. These questions were used to evaluate the selected Human 
& Experimental Toxicology articles. To limit the extent of this evaluation, articles published in 
the years 1984, 1994, 2004, and 2014 were selected, starting with the first issue of each year. 
Each article was independently evaluated by two assessors, and any discrepancies were resolved 
by consensus.  
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Results 
The four selected volumes of the journal included 530 articles, from which SciFinder retrieved a 
total of 541 different CAS numbers, of which a total of 122 were covered at least four times. 
However, this number includes substances of limited toxicity, such as water, normal components 
of the body, such as glutathione (45 articles), ascorbic acid (13), and a variety of enzymes. The 
industrial chemicals, excluding drugs, most commonly covered in Human & Experimental 
Toxicology are listed in Table 2. Metals are clearly in frequent focus (with a total of 126 article 
links), as are ethanol and certain pesticides, such as lindane and paraquat, though not in the more 
recent volumes. Of the 27 substances listed in Table 2, 15 are elements, mostly metals, but the 
list also includes five pesticides and three solvents (including ethanol). Among pharmaceuticals 
not included in the table, cisplatin (16), acetaminophen (8), propoxyphene (6), and acetylsalicylic 
acid (6) were the most popular.  
 When searching for the U.S.EPA’s list of 13 substances urgently requiring toxicological 
and exposure information,9 the SciFinder data indicated that none of them were reported at all in 
the four journal volumes examined. Additional searches were made for four substances that had 
been covered in at least ten articles in toxicology journals during 2000-2009,6 i.e., 1,3-
dichlorobenzene, bromochloromethane, triclocarban, and hexabromocyclododecane. Again, none 
of them was found in the Human & Experimental Toxicology volumes published between 2006 
and 2014.  
 In exploring how the results were presented and interpreted, the initial strategy turned out 
to be too ambitious, and a qualitative presentation of results seemed most appropriate. A 
thorough review was restricted to the first issue of each volume, but subsequent issues from the 
same year were also screened. In regard to the first question asked, almost all articles highlighted 
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uncertainties to some extent. However, almost all presented solely p values and relied on those 
when interpreting the results, usually without clear emphasis on limitations due to statistical 
power and other limitations. Standard deviations were often provided, especially in more recent 
articles, but confidence limits were generally not provided. In the discussion section, the articles 
reviewed frequently referred to results being “negative” if a significant difference (p < 0.05) was 
not observed. The findings were similar for environmental chemicals and drugs, and there 
appeared to be no obvious time trend.  
 
Discussion 
Human & Experimental Toxicology is a highly respected toxicology journal, and published 
articles are frequently cited, thus reflecting the journal’s high standing. The findings of the 
present study likely addresses publication practises that are typical of modern toxicology 
research. In agreement with a previous study of 72 toxicology and public health journals,6 the 
industrial chemicals most frequently covered in articles published in this journal were mainly 
ones commonly studied in the past and that continue to be featured in the toxicology literature.  
While more detailed exploration and verification of some of these well-studied 
substances may be possible to justify, such choices must be considered in the light of the 
concomitant lack of coverage of substances for which an urgent need for research has been 
announced. The present study therefore supports the existence of substantial inertia that favours 
research and publication on a limited number of substances rather than poorly-known chemicals 
for which documentation is in demand.  
An important reason for such inertia relates to the science paradigm that requires 
replication and verification to justify solid conclusions. In support of this tradition, many 
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preliminary findings that were highly publicized later proved to be wrong.13 As a result, both 
funding agencies14 and journals15 have announced their intention of increasing reproducibility of 
research. Although crucial to support the credibility of research, emphasis on replication can also 
have untoward effects, as certain environmental chemicals already trigger over 1,000 
publications per year.6 In this case, replication seems to be pursued to an extreme and perhaps 
counterproductive extent by merely extending the current focus on well-known hazards in 
toxicology. This phenomenon is well known in science and has been dubbed the “Matthew” 
effect (referring to the New Testament: “For unto every one that hath shall be given, and he shall 
have abundance: but from him that hath not shall be taken away even that which he hath”).16 
However, from an innovation point of view, and from the point of view of the PP, the opposite 
strategy, e.g. targeting newly recognized potential hazards or researching lesser known toxicants, 
would appear much more attractive. 
While research institutions, funding agencies, and the research community share a 
substantial part of the responsibility for the inertia, toxicology journals may too. Manuscripts on 
well-known substances are easier to find peer reviewers for, and they may be more likely to be 
cited. Perhaps some environmental chemicals are held in higher esteem than others, thereby 
adding to their continued prominence, or publication persistence, no matter what the societal 
needs may be. This means that there may be an element of circular reasoning involved, where a 
substance is a popular research item simply because it has been widely studied in the past – a 
self-prophetic bias that maintains a continued prominence of a specific scientific community and 
its publications.16 Science journals could likely play a role in inspiring change. Thus, otherwise 
excellent research may not represent a top priority for publication if it merely extends 
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unrestrained replication of well-known phenomena, and editors could instead assign higher 
priority to studies that explore new territory.  
A U.S. National Research Council committee recently called attention to the erroneous 
inference that chemicals are regarded inert or safe, unless proven otherwise.3 Thus, inconclusive 
studies have sometimes been labelled as “negative” or were thought to represent “no risk” rather 
than “uncertain information”.17 This tendency is clear also in the present journal, and it likely 
amplifies the tendency towards continuing research on particular substances, as uncertainties will 
always prevail on some aspect of their toxicological properties, thus appearing to justify 
continued research on this subject.  
This tradition appears even more misleading when the 5% limit is strictly applied, so that 
a greater emphasis is placed on results that have a p value of, say, 4.9% than on results with one 
of 5.1%,18 although there is of course no meaningful difference between outcomes with such 
similar p values. Adding further misperception, the null hypothesis is usually that an exposure 
has no effect. Thus, in toxicology research, the p value is frequently used to test a null hypothesis 
that may be unrealistic or obviously wrong, i.e. that lead exposure is not neurotoxic. A solution 
may be to test the results against a plausible alternative hypothesis, but such hypothesis may not 
be sufficiently specific to allow testing by Bayesian statistics.19  
Some scientists and some scientific journals oppose the reliance on p values.20 Instead of 
calculating whether the point estimate is “significantly” different from no effect, the confidence 
interval should be preferred.21 It represents the range of values within which 95% of effect 
estimates would likely fall if a large number of similar studies were conducted. In other words, 
given the point estimate and the calculated variability, the study would not be in disagreement 
with any hypothesis that postulated an effect within the confidence interval. If the interval 
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includes no effect or no difference, the deviation observed has not reached statistical 
significance. Still, the results can also be said to be in accordance with many other hypotheses, 
some perhaps suggesting a serious effect or a large difference. Such alternative interpretations 
are usually ignored, although the upper confidence limit may represent a plausible worst case 
scenario that should deserve attention. In agreement with this notion, the extreme confidence 
limit for the benchmark dose is used for risk assessment purposes.22 
The present review of articles from Human & Experimental Toxicology suggests that p 
values are still widely favoured and that the range of the confidence interval and its implications 
are rarely, if ever, considered. Further, the many factors listed in Table 1 that may bias the study 
findings towards the null are often ignored, thereby adding to the tendency towards 
underestimating toxic effects. Although other journals were not included in this study, Human & 
Experimental Toxicology most likely reflects tendencies that are typical for scientific journals in 
the field.  
Still, the risk of false positives should also be considered. Thus, within certain fields of 
biomedical research, a large proportion of published conclusions are claimed to be false.13 
Although that may be true for certain fields of research particularly affected by publication bias, 
the field of toxicology is different, especially in regard to the large number of industrial 
chemicals. In toxicology, the ratio of true to no relationships among the relationships probed in 
published studies is likely much higher than in most other fields. Thus, only a small percentage 
of industrial chemicals in use in the late 1970es were considered hazardous, while that was true 
for about 70% of new chemicals tested.23 The “untested chemicals assumption” therefore causes 
a very large proportion of false negative conclusions. In contrast, when scrutinising alleged false 
positive findings in environmental health and toxicology, very few such cases have been found.24 
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Thus, although publication bias could potentially cause a tendency of favouring false positive 
results in toxicology as in other fields, the impact is negligible in comparison with the huge 
number of environmental chemicals, for which virtually no toxicology information exists.  
Given the uneven research coverage of toxic hazards, interpretation of the evidence needs 
to address the following question:5 What could possibly be known, given the type of evidence 
available? Noisy studies, e.g. with imprecise estimates of the causative exposure and insensitive 
and nonspecific outcome measures, are likely to detect only the most serious risks. They should 
be cautiously interpreted in light of their (limited) weight of evidence. The fact that the null 
hypothesis could not be rejected with confidence may be irrelevant in such cases, and any 
support for the absence of toxicity would be very small. These considerations are of particular 
importance also in a wider perspective, as they are usually not dealt with in recommendations for 
systematic review.25-27 
The present study suggests that toxicology, as revealed by publications in Human & 
Experimental Toxicology, to some extent appears to fail the purpose of providing documentation 
needed by society in regard to preventing toxic hazards. Toxicology should not be credulous and 
overly generous accepting potentially causal associations so that it prevents the distinction 
between useful and misguided ideas. Still, inherent biases toward the null need to be recognized, 
and the logical error of assuming safety when a hazard could not be convincingly demonstrated 
in a “negative” study needs to be thwarted. The PP would seem to represent a proper antidote to 
this adverse tendency in toxicology.17  
Toxicology documentation must be acknowledged as provisional and dynamic. As the 
true extent of toxicity caused by industrial chemicals is poorly known, current knowledge most 
likely underestimates the adverse effects to a very considerable degree.7 Although this situation 
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might call for prudent precaution when interpreting toxicity data, the present study illustrates that 
a serious bias exists in the opposite direction, both in regard to the coverage of chemical hazards 
and in regard to the interpretation of research results. Toxicology information and risk 
assessment can never be complete, but can become less biased. Hence, there is room for 
improvement. While journal editors have little power to influence research planning, they can 
guide and inspire the reporting of results, thereby further improving the status and usefulness of 
toxicology research. Thus, this study suggests an additional and important role for Human & 
Experimental Toxicology to fill in the years to come.  
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Table 1. Examples of features that may bias toxicology toward missing a true association (false 
negative).5, 7   
 
Toxicological studies in general 
Low statistical power    
Use of 5 % probability level    
Pressures against false alarm   
Epidemiological studies of toxicants: 
Inappropriate control group  
Exposure misclassification   
Inadequate follow-up of exposed subjects (cases lost to follow-up, follow-up too short) 
Experimental toxicology: 
Exposure to single substances, one at the time   
Limited number of dose levels  
Exposure duration less than lifetime  
Standard, non-specific effect measures 
Inbred strains to limit genetic variability   
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Table 2.  Industrial chemicals covered in at least five articles in the four volumes (total number 
of articles published in parenthesis). 
Name CAS# 
1984 
(203) 
1994 
(136) 
2004 
(83) 
2014 
(108) 
Total 
(530) 
Ethanol 64-17-5 6 6 6 2 20 
Mercury 7439-97-6 7 7 2 16 
Copper 7440-50-8 5 5 2 1 13 
Lead 7439-92-1 4 4 3 2 13 
Nickel 7440-02-0 6 6 12 
Zinc 7440-66-6 5 5 1 11 
Lindane 58-89-9 5 5 10 
Paraquat 4685-14-7 5 5 10 
Acrolein 107-02-8 3 3 2 8 
Cadmium 7440-43-9 4 4 8 
Mustard gas 505-60-2 4 4 8 
Nitric oxide 10102-43 1 1 3 3 8 
Iron 7439-89-6 5 2 7 
Arsenic 7440-38-2 3 3 1 7 
Manganese 7439-96-5 3 3 1 7 
Aluminum 7429-90-5 2 2 2 6 
Chromium 7440-47-3 3 3 6 
Ethylene glycol 107-21-1 3 3 6 
Fluazifop-butyl 69806-50 3 3 6 
Nitrogen dioxide 10102-44 3 3 6 
Selenium 7782-49-2 4 1 5 
p,p′-DDT 50-29-3 1 1 2 1 5 
Carbon tetrachloride 56-23-5 2 2 1 5 
Cotinine 486-56-6 2 2 1 5 
Cypermethrin 52315-07 2 2 1 5 
Lithium 7439-93-2 2 2 1 5 
Magnesium 7439-95-4 2 2 1 5 
Ozone 10028-15 2 2 1 5 
Platinum 7440-06-4 2 2 1 5 
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